Influence of antipsychotics on mortality in schizophrenia: systematic review.
about
Dietary advice for people with schizophreniaMaintenance treatment with antipsychotic drugs for schizophreniaPhysical health care monitoring for people with serious mental illnessOral health advice for people with serious mental illnessOral health advice for people with serious mental illnessPhysical health care monitoring for people with serious mental illnessPhysical health care monitoring for people with serious mental illnessEvaluation of different approaches for confounding in nonrandomised observational data: a case-study of antipsychotics treatment.Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control studyExercise therapy in adults with serious mental illness: a systematic review and meta-analysisOptimizing psychosocial interventions in first-episode psychosis: current perspectives and future directionsAll-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study.Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Schizophrenia: overview and treatment options.Mortality in schizophrenia: a measurable clinical endpointAre there modifiable risk factors which will reduce the excess mortality in schizophrenia?Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort.Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.Almost all antipsychotics result in weight gain: a meta-analysis.Antipsychotic treatment and mortality in schizophrenia.Ten-Year Outcomes of First-Episode Psychoses in the MRC ÆSOP-10 Study.Treatment-resistant Schizophrenia: Evidence-based StrategiesDo routine outcome monitoring results translate to clinical practice? A cross-sectional study in patients with a psychotic disorderCardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study.Evidence review and clinical guidance for the use of ziprasidone in Canada.Adult medication-free schizophrenic patients exhibit long-chain omega-3 Fatty Acid deficiency: implications for cardiovascular disease risk.Association Between Antipsychotic Treatment and Advanced Diabetes Complications Among Schizophrenia Patients With Type 2 Diabetes Mellitus.Guideline-concordant antipsychotic use and mortality in schizophrenia.Mortality Rates in Users of Typical and Atypical Antipsychotics: A Database Study in PolandShared decision making for psychiatric medication management: beyond the micro-social.Do doctors agree on doses of antipsychotic medications?Antipsychotic polypharmacy in schizophrenia: benefits and risks.Management of schizophrenia in late life with antipsychotic medications: a qualitative review.A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications.Policy and service development implications of the second Australian National Survey of High Impact Psychosis (SHIP).Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness.The need for experience focused counselling (EFC) with voice hearers in training and practice: a review of the literature.Oral health education (advice and training) for people with serious mental illness.
P2860
Q24186009-B2A58701-C58D-44BF-8A6C-E9D4987D8CC5Q24197902-444A30DD-3255-4DEF-A4E9-79EDDFD0A520Q24201094-C1A90D84-6F90-4A7E-86D5-3A3A778E963BQ24234252-651C52C2-3529-438B-A59A-8CF255C3BF09Q24235013-743EBE00-E7F0-442F-B106-025026D7EBBEQ24236698-DAFB2E97-E2DB-4023-8A79-119164204E42Q24241183-94E22A05-CA47-4C93-8037-542B00E4F858Q30792325-204EE04F-9B4D-46AD-ACA9-48E5277329DAQ30993822-C11AC9BD-B27A-45A3-B6AF-4D2E42BFBE30Q33600284-A374499A-6D08-4F12-BD76-E557147E4A84Q33631663-640AB73E-49CC-4AC9-9ADD-FE52ED388CE9Q33710004-F0DDEBED-7779-4952-860D-8510B9968DB4Q33878816-B2E10865-FAB1-46ED-9043-BD85A887EA77Q34154951-2DDCC2C4-B0A5-47B7-90A7-8D0D6D433140Q34183484-43D0C4D0-6517-44B8-A956-A25A0A393CD8Q34183495-93FE8A12-27FD-4C83-8B62-6BD436E94571Q34248044-B16CAA26-F997-43A7-9635-9A22D2F828B3Q34440708-4F4ABDCD-FA4C-415D-A0FD-B56C05DDE722Q34523396-0A2F117F-47BE-489D-A8AC-89D41A0A4A9FQ34631699-EEC1BC47-E3B3-4BA3-BB40-E5BFA9D405BDQ34661499-30C529AF-9220-4F85-80B9-CDC51C451E88Q35369872-0EFFAB1C-FDEA-4322-AFC7-0DEA701131CEQ35552486-37E9CAB0-FBB9-43CD-911E-4B1ECB8FBF53Q35964353-A38D2393-9D19-4B5B-ABCB-6D53EF7257B2Q35993230-78F73913-55B2-4E6C-9C73-1E96F2C8B7EFQ36198276-FB658395-8C4D-452B-9967-8862DB49DF9AQ36588607-946CA87B-8195-4716-9138-C6C7FDF83EC7Q36692065-FEF9F54F-204C-4224-9EF2-4CC1DDA52BD4Q36817257-D1539FDA-08A0-44A6-8727-3514A095CFD2Q37131022-A3E89B48-82A3-44FC-A489-232B400CC26FQ37297922-05C5B0DD-9FB1-485E-B1AD-DE811B8A540EQ37316514-FE8C5ED7-DBB7-46E6-907A-20FBD4806AD3Q37514630-64C7E3EC-C35C-492E-8736-6A00E5B0B696Q37863093-F5094FA9-DF46-427E-B4AD-81DE3BF0AA4FQ37960898-DA19D783-41BB-4533-ABEA-4CD4058E113EQ37998841-A602948A-0A24-42A0-B07D-8F0B3F8FE6FFQ38007928-26C1657A-30D4-49DB-92F0-AE90AFE0254EQ38081872-9BC0A9A5-97A9-44F0-9DA6-3AA2D29C2413Q38109947-59FA5BBD-3EB1-42D3-9F84-C257EB1A10FCQ38949178-522F258F-0E88-4212-90F1-1A7CE3C91578
P2860
Influence of antipsychotics on mortality in schizophrenia: systematic review.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Influence of antipsychotics on mortality in schizophrenia: systematic review.
@ast
Influence of antipsychotics on mortality in schizophrenia: systematic review.
@en
Influence of antipsychotics on mortality in schizophrenia: systematic review.
@nl
type
label
Influence of antipsychotics on mortality in schizophrenia: systematic review.
@ast
Influence of antipsychotics on mortality in schizophrenia: systematic review.
@en
Influence of antipsychotics on mortality in schizophrenia: systematic review.
@nl
prefLabel
Influence of antipsychotics on mortality in schizophrenia: systematic review.
@ast
Influence of antipsychotics on mortality in schizophrenia: systematic review.
@en
Influence of antipsychotics on mortality in schizophrenia: systematic review.
@nl
P1476
Influence of antipsychotics on mortality in schizophrenia: systematic review
@en
P2093
Stefan Weinmann
Volkmar Aderhold
P356
10.1016/J.SCHRES.2009.05.018
P407
P50
P577
2009-06-12T00:00:00Z